Arksarapuk Jittirat is a Nephrology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 19 publications with 557 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Suite Mather 1800
Cleveland, OH 441061716
Telephone
216-844-5685Provider last certified this registry record 9 Nov 2020.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20252 payments
- Calliditas Therapeutics US Inc.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
48.4%Beta blocker12.4%Carvedilol69%Metoprolol Tartrate23%Metoprolol Succinate5%Labetalol Hcl3%Part D<11 patientsCalcium channel blocker10.7%Amlodipine Besylate84%Nifedipine Er16%Part D≥132 patients+ 11 more classes in this area
Metabolism & gastrointestinal
29.4%Corticosteroid17%Prednisone100%Part D≥201 patientsProton pump inhibitor7.1%Pantoprazole Sodium80%Omeprazole20%Part D≥75 patients+ 7 more classes in this area
Hormonal (systemic)
6.2%Calcium-sensing Receptor Agonist5.7%Cinacalcet Hcl100%Part D≥63 patientsl-Thyroxine0.4%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Induction of immune tolerance in living related human leukocyte antigen–matched kidney transplantation: A phase 3 randomized clinical trial
American Journal of Transplantation
2025 - Transmission of <i>Ehrlichia chaffeensis</i> From an Organ Donor to a Kidney–Pancreas Transplant Recipient
Transplant Infectious Disease
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”